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ABSTRACT
The non-essential VTS1 gene of Saccharomyces
cerevisiae is highly conserved in eukaryotes and
encodes a sequence- and structure-specific RNA-
binding protein. The Vts1 protein has been
implicated in post-transcriptional regulation of a
specific set of mRNAs that contains its-binding
site at their 30-untranslated region. In this study,
we identified VTS1 as a multi-copy suppressor
of dna2-K1080E, a lethal mutant allele of DNA2
that lacks DNA helicase activity. The suppression
was allele-specific, since overexpression of Vts1
did not suppress the temperature-dependent
growth defects of dna2D405N devoid of the
N-terminal 405-amino-acid residues. Purified
recombinant Vts1 stimulated the endonuclease
activity of wild-type Dna2, but not the endonuclease
activity of Dna2"405N, indicating that the activation
requires the N-terminal domain of Dna2. Stimulation
of Dna2 endonuclease activity by Vts1 appeared
to be the direct cause of suppression, since the
multi-copy expression of Dna2-K1080E sup-
pressed the lethality observed with its single-
copy expression. We found that vts1D dna2D405N
and vts1Ddna2-7 double mutant cells displayed
synergistic growth defects, in support of a func-
tional interaction between two genes. Our results
provide both in vivo and in vitro evidence that
Vts1 is involved in lagging strand synthesis by
modulating the Dna2 endonuclease activity that
plays an essential role in Okazaki fragment
processing.
INTRODUCTION
Chromosomal DNA replication in eukaryotes requires the
coordinated action of a large number of replication factors
(1–5). Unlike leading strand DNA synthesis, lagging
strand DNA synthesis proceeds discontinuously via the
generation of Okazaki fragments. DNA polymerase
(pol) a-primase ﬁrst synthesizes  10 nucleotides (nt) of
RNA, followed by the addition of short DNA stretches
(6,7), which are designated ‘RNA–DNA primers’. These
are diﬀerent from the RNA-only primers observed in
prokaryotes. The second DNA polymerase, pol d,
extends the RNA–DNA primers to form new Okazaki
fragments with the aid of proliferating cell nuclear
antigen (PCNA) and replication factor C (RFC). Pol d
not only extends the newly synthesized Okazaki fragments
but it also creates ﬂap structures by displacing the 50-end
region of downstream Okazaki fragments (8,9). Flaps can
be processed by nucleases to form ligatable nicks, which
are sealed by DNA ligase I to produce continuous
double-stranded (ds) DNA. Short ﬂap regions can be
removed by the activity of ﬂap endonuclease 1 (Fen1),
which is a structure-speciﬁc endonuclease (10–12).
However, when the ﬂap region is relatively long
(>20nt), ﬂap cleavage requires Dna2, an endonuclease/
helicase (8,13). Replication protein A (RPA) can bind eﬃ-
ciently to DNA ﬂaps longer than 27nt in length, which
inhibits Fen1 activity. In contrast to Fen1, RPA-bound
ﬂaps are eﬃciently cleaved by Dna2 because its
endonuclease activity is markedly stimulated (13). Thus,
RPA can act as a nuclease switch for the sequential pro-
cessing of long ﬂaps that are processed ﬁrst by Dna2, and
then by Fen1 to form a nick.
Although the majority of Okazaki fragments appear to
be removed in vitro via generation of short ﬂaps in a
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generated in vitro are long (11), and their processing
requires both Fen1 and Dna2. Therefore, both pathways
are essential for processing of all ﬂaps. In vivo, however,
the level of long and/or short ﬂaps formed is not known.
The production of long ﬂaps can be inﬂuenced by the
failure of cleavage at the early stages in strand displace-
ment reaction due to inadequate Fen1 activity, enhanced
strand displacement by pol d (14) or the failure of 30!50
proofreading function of pol d (11,15). Alternatively, there
may be sequences that can be more readily displaced by
pol d. All of these factors can lead to elevate the levels of
long ﬂaps.
In order to gain more insights into the processing
of long ﬂaps by Dna2, we searched for genetic suppres-
sors that could rescue a particular defect caused by a
mutation in DNA2. This approach identiﬁed the
non-essential VTS1 gene of S. cerevisiae as a suppres-
sor of the dna2-K1080E mutant (glutamate substitu-
tion for lysine at position 1080, the ATP-binding
motif), which lacks ATPase/helicase activities (16–18).
VTS1 was originally identiﬁed in S. cerevisiae as a
multi-copy (and low-copy) suppressor of vti1–2 mutant
cells that displayed defects in growth and vacuole trans-
port (19). However, it is not clear whether Vts1 is directly
involved in vesicle traﬃcking (19). One notable struc-
tural motif present in Vts1 is the sterile-a motif (SAM)
domain. This domain is highly abundant in eukaryotes
and known to mediate protein–protein interactions
for transcription regulation, signal-transduction cas-
cades and nucleic acid binding (20–22). A subclass of
SAM domain can bind RNA (22–25). For
example, both Vts1 of S. cerevisiae and Smaug of
Drosophila melanogaster recognize and bind RNAs pos-
sessing a speciﬁc structure (named SRE, SMAUG recog-
nition element) (22). This structural element consists of a
RNA stem and a pentanucleotide loop (pentaloop;
CNGGN, N for any nucleotide) (22,26,27). Disruption
of the stem or a single base change in any of the three
conserved nucleotides in the pentaloop signiﬁcantly
reduced the RNA-binding activity of Smaug or Vts1
(22,28). Conversely, a single amino acid substitution in
the SAM domain of Smaug or Vts1 abolished its ability
to bind the RNA-stem-loop structure. Consistent with the
role of Smaug in Drosophila, S. cerevisiae Vts1 regulated
the stability of artiﬁcial mRNAs containing an SRE at
their 30-untranslated region (22). However, target
mRNAs that are regulated by Vts1 have not been
identiﬁed yet.
The SAM domain has also been implicated in DNA
binding. For example, the RuvA subunit, a component
of the prokaryotic RuvABC complex that processes
recombination intermediates, contains this domain
that is required for binding Holliday junction struc-
tures (29). Since VTS1 was isolated as a suppressor of
defects in Okazaki fragment processing, we investigated
its biochemical interactions with Dna2 and Fen1. In this
study, we present both in vitro and in vivo evidence that
Vts1 is involved in Okazaki fragment processing by
modulating the endonuclease activity of Dna2.
MATERIALS AND METHODS
Chemicals, nucleotides, enzymes and DNA
The oligonucleotides (listed in Table 1) used to construct
various DNA substrates were synthesized commercially
from Genotech (Daejeon, Korea) and gel-puriﬁed
prior to use. Nucleoside triphosphates and DNase I
were obtained from Sigma-Aldrich. [g-
32P] ATP
(>5000Ci/mmol) and [a-
32P] dCTP (>5000Ci/mmol)
were purchased from IZOTOP (Budapest, Hungary).
Restriction endonucleases, PCR polymerases, Klenow
Fragment (30!50 exo
 ) were purchased from either New
England Biolabs (Beverly, MA) or Enzynomics
TM
(Daejeon, Korea). The pRS plasmids were purchased
from New England Biolabs. The pET28 vectors used
for protein expression in Escherichia coli were from
Novagen (Darmstadt, Germany). Isopropyl b-D-
1-thiogalactopyranoside (IPTG) and X-gal were from
ElpisBiotech, Inc. (Daejeon, Korea). Imidazole was from
Acros Organics (Geel, Belgium), and 5-ﬂuorooritic acid
(5-FOA) was obtained from Duchefa Biochemie
(Haarlem, the Netherlands).
Dna2, Dna2405N and Dna2
(1–405) (an N-terminal
405-amino-acid fragment of Dna2) were puriﬁed as
described previously (9). Rad27 (yeast Fen1) was
puriﬁed as described (13).
Preparation of the substrates
The position of radio-isotopic label in the substrates
and substrate structures are indicated in each ﬁgure.
Oligonucleotide labeling at its 50-end by incorporating
[g-
32P]ATP with T4 polynucleotide kinase was described
previously (30). To label at 30-end, downstream oligo-
nucleotide was ﬁrst annealed to the template and
upstream oligonucleotides in a molar ratio of 1:1.2:1.4
(downstream/template/upstream oligonucleotides, respec-
tively). The annealing reaction was performed by using
PCR machine (95 C, 5min; 65 C, 30min;  0.5 C/min).
Note that downstream oligonucleotide is two nucleotide
shorter when annealed with template oligonucleotide
(Table 1). Annealed substrate was then labeled at 30-end
of downstream oligonucleotide by incorporating [a-
32P]
dCTP with Klenow Fragment (30!50 exo
 ), and then
chased with excess amount of cold dCTP. The resulting
ﬂap substrate was gel-puriﬁed prior to use.
Construction of yeast strains
S. cerevisiae strains used in this study were as follows:
YPH499 (MATa ade2-101 ura3-52 lys2-801 trp1-63
his3-200 leu2-D1 GAL
+), YJA2 (MATa ade2-101
ura3-52 lys2-801 trp1-63 his3-200 leu2-D1 GAL
+
dna2D405N), YJA1B (MATa ade2-101 ura3-52 lys2-801
trp1-63 his3-200 leu2-D1 GAL
+ dna2::HIS pRS316-
DNA2), 4053-5-2 (MATa trp1 leu2 ura3 his7 can1) and
7720-x (MATa trp1 leu2 ura3 his7 can1 dna2-x) (31). The
VTS1 gene was disrupted from YPH499 and YJA2 by
replacing it with the HIS3 gene. In order to perform
one-step gene disruption, two primers were used: VH-F
(50-GTT AAT GGT TAT ACA GCT GCC ATT TGA
CCG TGC ACC ACA GCA AAT TAT Cct gag agt gca
1584 Nucleic Acids Research, 2010,Vol.38, No. 5cca taa ttc-30) and VH-R (50-GTT AAG TAA ATA GTT
TTA TGC CAT TAA ACG GTG CAA AAA CAG GTG
TAA TCg cat atg atc cgt cga gtt c-30). The sequences in
capital letters are homologous to the ﬂanking sequences of
the VTS1 open reading frame (ORF), while sequences in
small letters are homologous to HIS3. Using these two
primers and pRS303 (with His3
+ as a selection marker)
as the template, the HIS3 gene was ampliﬁed. The
ampliﬁed fragments thus contained the HIS3 gene
ﬂanked by upstream and downstream sequences of
VTS1 and were transformed into YPH499 and YJA2.
Transformants that grew in the histidine-dropout
medium were analyzed for correct disruption.
The VTS1 gene was also disrupted in 7720-x strains,
which possess diﬀerent point-mutations in DNA2,b y
replacing it with the LEU2 gene. Two primers, VL-1
(50-GCa agc ttG ACT TTC TCA TCG ATG TTG TGC
CTA GAA G-30) and VL-2 (50-GCg gat ccG ATT TCT
TTG CTG ACA ATT ACT TTA TAT G-30), were used to
amplify the upstream region of VTS1 ORF. VL-3 (50-GCc
tcg agG AAC ATA TTT CAT TTA TTT TGT AAT TTT
AAC-30) and VL-4 (50-GCa agc ttC ATT TAC TAC TAG
TAT ATT TCC TTT TGT GAA G-30) were used to
amplify the downstream region of VTS1 ORF. Small
letters in these sequences indicate restriction enzyme sites
for ligation into the pRS305 vector. The PCR products
(each, 350bp) were cloned into pRS305 (with Leu2
+ as a
marker) and digested with HindIII. The resulting
linearized DNA was transformed into each of the 7720-x
dna2 mutant strains. Transformants were then spread on
leucine-dropout media and analyzed by PCR and
Southern blotting.
YPH499 (VTS1-FLAG) is a strain in which the
endogenous VTS1 gene was 5 FLAG-tagged at its
C-terminus. The 5 FLAG sequence with the KanMX
gene was from the pKL258 vector. Two primers,
VFLAG-1 (50-GAA TCG TTA TTG ATT GAT TAC
AAA GAA CGT GAT TTA ATT GAT AGA TCT
GCT TAT cgt acg ctg cag gtc gac-30) and VFLAG-2
(50-CAA AGT AAA TAA AAA TTA AAT ATT TAT
GCA ACG TCA AGA CAA TCA Act cga tga att cga
gct cg-30), were used to amplify the DNA fragment using
pKL258 as a template. The sequences in capital letters in
VFLAG-1 and VFLAG-2 are homologous to the
upstream and downstream sequences, respectively, of the
stop codon in the VTS1 ORF. The sequences in small
letters in both primers are homologous to ﬂanking
sequences of the 5 FLAG plus KanMX gene in pKL258
vector. Thus, the ampliﬁed fragments contained the
5 FLAG and KanMX gene ﬂanked by sequences
upstream and downstream of the VTS1 stop codon and
were used for integration into the C-terminus of VTS1
ORF by homologous recombination. Transformants that
grew in YPD containing G418 were selected and analyzed
by PCR and western blotting.
Measurement of growth rate
The rate of cell growth was measured by counting cell
numbers using a hematocytometer. Cells were ﬁrst
inoculated in 2ml of YPD liquid media and grown at
25 C until saturation. The cells were then diluted in
30ml of fresh YPD media to a concentration of 1 10
6
cells/ml ( 0.1 of A600) and incubated at 32 Ci na
shaking incubator. Aliquots containing the same number
of cells of each strain were withdrawn at indicated times
and subjected to brief sonication to disperse clumped cells,
and then vortexed for 30s to generate homogeneous
suspension.
Cell growth defects were examined by the drop-dilution
assay. Cells were inoculated in 2ml YPD liquid media and
grown at 25 C until saturation. The cells were then diluted
to a concentration of 1 10
7 cells/ml ( 1.0 of A600) and
spotted in 10-fold serial dilutions (10
5,1 0
4,1 0
3 and 10
2
cells) on YPD plates. Plates were incubated at diﬀerent
temperatures (25 C and 30 C) for 3 days.
Puriﬁcation of recombinant Vts1
The VTS1 ORF was inserted into pET28 vector that
expresses the ORF as an N-terminal 6 His-tagged
protein. The pET28-Vts1 plasmid was transformed into
E. coli BL21 (CodonPlus), and cells (1l) were grown at
25 C until the A600 value reached 0.5. At this point, cells
were induced with 0.1mM IPTG (ﬁnal concentration) for
4h. Cells were harvested by centrifugation and the cell
pellet was resuspended in 30ml of buﬀer T500 [50mM
Tris–HCl/pH 8.0, 500mM NaCl, 10% glycerol, 0.1%
Table 1. Oligonucleotides used for construction of substrates
No. Nucleotide sequences (length in nt) Name
15 0-GAAAACATTATTAATGGCGTCGAGCTAGGCACAAGGCGAACTGCTAACGG-30 (50) 5TY-1
25 0-GGAAAACATTATTAATGGCGTCGAGCTAGGCACAAGGCGAACTGCTAACGG-30 (51) 5TY
35 0-CCGTTAGCAGTTCGCCTTGTGCCTAGCTCGACGCCATTAATAATGTTTTC-30 (50) ANTI-5TY-1
45 0-CCGTTAGCAGTTCGCCTTGTGCCTA-30 (25) 5TB
55 0-CCGTTAGCAGTTCGCCTTGTGCCTAG-30 (26) 5TBG
65 0-CGCTCGACGCCATTAATAATGTTTTC-30 (26) 729-FLAP-1
75 0-CGAACAATTCAGCGGCTTTAACCGGACGCTCGACGCCATTAATAATGTTTTC-30 (52) 729
85 0-GCTCGACGCCATTAATAATGTTTTC-30 (25) 5TA
95 0-CTCGACGCCATTAATAATGTTTTC-30 (24) 5TA-1
10 50-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCGGACGCTCGACGCCATTAATAATGTTTTC-30 (60) T60
11 50-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCGGACGCTCGACGCCATTAATAATGTTTT-30 (59) T60-CH-1
12
b 50-GCUCGAGGCUCUGGCAGCCUCGAGC-30 (25)
a SRE-RNA
aUnderlined are inverted repeat sequences that form hairpin or stem structure.
bRibooligonucleotide.
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ﬂuoride (PMSF), 0.1mM benzamidine, 1.25mg/ml
leupeptin and 0.625mg/ml pepstatin A]. The subscript
number in T500 indicates the concentration of NaCl
inmM. Then, cells were sonicated for four cycles with a
1-min interval on ice. The supernatant was adjusted to
5mM imidazole (IDZ, ﬁnal concentration). A Ni
2+-
NTA agarose (1.5ml, Qiagen; Valencia, CA) column
was pre-equilibrated with T500 plus 5mM IDZ. In all sub-
sequent steps, the ﬁnal concentration of NP-40 in T500 was
reduced to 0.02%. The supernatant was loaded onto a
Ni
2+-NTA agarose column. The column was then
washed with 5-column volumes of T500 plus 70mM IDZ,
and eluted with T500 plus 480mM IDZ. The eluate was
subjected to glycerol gradient sedimentation (5ml,
15–35% glycerol in buﬀer T500) at 48000r.p.m. for 24h
in a SW55 Ti rotor (Beckman). Fractions (250ml each)
were collected from the bottom of the tube. Peak fractions
were stored at  80 C. The Vts1-A498Q mutant and
Vts1
(1 406) were puriﬁed using the same procedure as
described above. Vts1
SAM was also puriﬁed similarly,
but most of proteins were eluted in the 70mM IDZ
wash from the Ni
2+-NTA agarose column.
Nuclease assays
Standard nuclease assays were performed in reaction
mixtures (20ml) containing 50mM Tris–HCl/pH 7.8,
2mM MgCl2, 2mM DTT, 0.25mg/ml BSA, 62.5mM
NaCl and 15fmol of DNA substrate. Reactions were
incubated at 37 C for 15min, followed by the addition
of 4mlo fa6  stop solution (60mM EDTA/pH 8.0,
40% sucrose, 0.6% SDS, 0.25% BPB, 0.25% xylene
cyanol). The products were subjected to electrophoresis
for 30min at 150V in 0.5 TBE (45mM Tris, 45mM
boric acid and 1mM EDTA). The gels were dried on a
DEAE-cellulose paper and autoradiographed. Labeled
DNA products were quantiﬁed with the use of a
Phosphor Imager (BAS-1500, Fujiﬁlm).
Electrophoretic mobility shift assay
Reaction mixtures (20ml) containing 50mM Tris-HCl/pH
7.8, 5% glycerol, 2mM DTT, 0.25mg/ml BSA, 37.5mM
NaCl, 5fmol of labeled DNA substrate and indicated
amounts of Vts1 or its derivatives were preincubated on
ice for 10min, followed by incubation at 37 C for 5min.
Complexes formed were resolved in a 5% polyacrylamide
gel in 0.5 TBE at 4 C, and the amount of complex
formed was measured using a Phosphor Imager.
Alkaline protein extraction from S. cerevisiae
The expression level of proteins in yeast was determined
after alkaline protein extraction. YJA1B harboring
pRS314-dna2-K1080E, pRS316-DNA2 and the pRS325-
suppressor gene were grown to saturation. Expression of
the suppressor gene cloned in pRS325 was driven by a
constitutive ADH1 promoter or its native promoter.
Cells (5 10
7, total) were harvested and resuspended in
the lysis buﬀer (150ml; 1.85M NaOH, 7.5%
b-mercaptoethanol). Then, the mixture was incubated on
ice for 10min. TCA (20% v/v, 150ml) was added and
incubated on ice for an additional 10min. Samples were
then centrifuged at 4 C for 5min at 20000g in an
Eppendorf centrifuge. Supernatants were discarded, and
1 SDS sample buﬀer was added to the precipitated mate-
rials. The samples were neutralized with 1–2mlo f2 M
Tris/pH 11.0, and resuspended by rigorous vortexing
after 30min of incubation at 60 C, followed by boiling
for 10min. The samples were then subjected to
electrophoresis in a 10% SDS–PAGE gel. Gels were
Coomassie-stained and analyzed by western blotting.
Enzyme-linked immunosorbent assay
ELISA was used to detect the physical interaction between
Dna2 and Vts1 as described previously (32) with some
modiﬁcations. Vts1 was diluted to a concentration of
10nM in the carbonate buﬀer (16mM Na2CO3/34mM
NaHCO3, pH 9.6). Vts1 was then added to appropriate
wells of a 96-well ELISA plate (100ml/well), and the plate
was incubated for 2h at 25 C. As control, BSA was
substituted for Vts1 in the coating step. Wells were
aspirated and washed three times with the wash buﬀer
(50mM Tris–HCl/pH 7.5, 200mM NaCl, 2.5mM KCl,
0.05% Tween 20). The blocking buﬀer (50mM Tris–
HCl/pH 7.5, 150mM NaCl, 2.5mM KCl, 0.05% Tween
20 and 3% BSA) was added and the mixture was
incubated for 2h at 25 C. Wells were aspirated and
washed three times with the blocking buﬀer.
Preparations of Dna2, Dna2405N and Dna2
(1–405)
were serially diluted (as indicated) in the binding buﬀer
(50mM Tris–HCl/pH 7.5, 100mg/ml BSA, 200mM NaCl
and 0.02% NP-40), and then added to Vts1-coated wells
(100ml/well). The plates were incubated for 30min at
25 C. Wells were aspirated and washed four times with
the binding buﬀer. Primary antibodies (rabbit polyclonal
antibodies against Dna2) were diluted 2000-fold in the
blocking buﬀer, added to appropriate wells. The
mixtures were then incubated for 1h at 25 C. Wells were
aspirated and washed ﬁve times with the blocking buﬀer.
Secondary antibodies, diluted 10000-fold in the conjugate
buﬀer (50mM Tris–HCl/pH 7.5, 150mM NaCl, 0.05%
Tween 20, 1% BSA), were added to appropriate wells
and the mixtures were incubated for 30min at 25 C.
Wells were aspirated and washed ﬁve times with the con-
jugate buﬀer. Dna2–Vts1 complexes were detected using
the TMB substrate (Sigma). Absorbance readings were
corrected by subtracting background absorbance
generated with BSA-coated control wells.
DNA footprinting
Reaction mixtures (20ml) contained 50mM Tris–HCl/pH
7.8, 2mM DTT, 5% glycerol, 0.25mg/ml BSA, 62.5mM
NaCl, 20fmol of DNA substrate and indicated amounts
of Vts1. Reaction mixtures were preincubated at 4 C for
10min, followed by further incubation at 37 C for 5min
to allow Vts1 to bind DNA substrates. In order to cleave
unprotected regions in the DNA substrate, DNase I was
added as indicated in each experiment with 2mlo f
10 Ca
2+/Mg
2+ buﬀer (5mM CaCl2, 25mM MgCl2).
The mixtures were then incubated at 4 C for 10min,
1586 Nucleic Acids Research, 2010,Vol.38, No. 5treated with 2 stop buﬀer (23ml; 20mM EDTA/pH 8.0,
95% formamide, 0.25% xylene cyanol) and boiled for
5min. Samples were subjected to electrophoresis for
1.5h at 30W in 1 TBE (90mM Tris, 90mM boric acid
and 2mM EDTA) through a 15% denaturing gel contain-
ing 7M urea.
Isolation of yeast nuclei
Cells (25ml) were grown in YPD to A600=1.5, harvested
and resuspended in 1ml of 50mM Tris/pH 7.5 and 30mM
DTT. After incubation at 30 C for 15min, cells were
centrifuged for 3min in 1700g (Sorvall SS-34 rotor), and
pellets were resuspended in 667ml of YPD/S (YPD with
1M sorbitol). Then, 333ml of 2M sorbitol was added,
followed by the addition of 10ml of 4mg/ml lyticase
(Sigma). Samples were then incubated for 45min at
30 C; this treatment resulted in eﬃcient formation
of spheroplasts ( 90%). The spheroplasts were collected
by centrifugation, resuspended in 1ml of YPD/S and
incubated at 30 C for 15min to allow cells to recover.
After one additional wash cycle at 4 C, cells were
resuspended in 800ml of buﬀer N (25mM K2SO4,
30mM HEPES-NaOH/pH 7.5, 5mM MgSO4,1 m M
EDTA, 10% glycerol, 0.5% NP-40, 3mM DTT and
protease inhibitors). Cells were homogenized with 15–20
gentle strokes and stored at 4 C to permit cell debris to
settle. The supernatant (nuclei+cytoplasmic compo-
nents) was centrifuged in 3800g (Sorvall SS-34 rotor) in
order to pellet nuclei. The supernatant, designated
‘cytoplasmic fraction’, was used in this experiment. The
pellet fractions containing nuclei and/or cell debris were
resuspended in the same volume of buﬀer N as described
for the isolation of the cytoplasmic fraction. Equal
volumes of each fraction were then loaded on a 10%
SDS–PAGE gel for western blotting.
RESULTS
Vts1 is an allele-speciﬁc suppressor of dna2 mutations
To better understand mechanistic aspects of Dna2 during
processing of Okazaki fragments, we searched for novel
proteins that function jointly with Dna2 endonuclease/
helicase. This screen identiﬁed VTS1 as a multi-copy sup-
pressor of dna2-K1080E, a mutant allele devoid of helicase
activity. Subsequent subcloning conﬁrmed that the
multi-copy expression of VTS1 alone was suﬃcient to
suppress the Dna2 helicase-deﬁcient mutant. As shown
in Figure 1A, pRS325 empty vector, pRS325-DNA2 and
pRS325-VTS1 were separately transformed into the
dna2D YJA1B strain that harbors both pRS314-
dna2-K1080E and pRS316-DNA2. Plasmids pRS314,
pRS316, and pRS325 contained Trp1
+, Ura3
+ and
Leu2
+, respectively, as a selection marker. All
transformants were able to grow in the absence of
5-FOA (Figure 1A, left). When cells were grown in the
presence of 5-FOA, only cells that had lost Ura3
+-
pRS316 (hence wild-type DNA2) could grow. In the
presence of pRS325-VTS1, the YJA1B strain could grow
with pRS314-dna2-K1080E only and did not require
pRS316-DNA2 any longer (Figure 1A, right), indicating
that multi-copy expression of VTS1 suppressed the
growth defects of dna2-K1080E. In contrast, VTS1 expres-
sion failed to restore growth of either dna2-E680A or
dna2D405N mutant cells (Figure 1B and C), which lack
endonuclease activity and the N-terminal 405-amino-acid
domain, respectively. These results indicate that suppres-
sion by Vts1 requires both the endonuclease activity and
the N-terminal domain of Dna2.
The vts1" dna2 double mutant displays synergistic
growth defects
We expected that vts1D dna2 double mutation would lead
to more severe growth defects than that caused by a single
mutation alone. Since both dna2-K1080E and dna2-E680A
cells are not viable, this analysis was not feasible
(Figure 1B and C). Instead, we examined the growth
of vts1D dna2D405N (Figure 2A) and vts1D dna2-7
(Figure 2B) under semipermissive conditions. The dna2-7
allele contains an aspartic acid for glycine substitution at
position 913 that renders the dna2-7 mutant cells both
temperature- and MMS-sensitive (31). When grown at
32 C (a semipermissive temperature for dna2D405N),
A
B
C
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none
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YJA1B + pRS314-dna2-K1080E
1
2
3
1
2
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1
2
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YJA2 (dna2D405N)
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YJA1B + pRS314-dna2-E680A
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none
VTS1
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Figure 1. VTS1 is a multi-copy suppressor speciﬁc for Dna2-K1080E, a
Dna2 helicase-negative mutant. (A) Overexpression of VTS1 suppresses
the dna2 helicase-negative mutant. The dna2D strain YJA1B harboring
both pRS314-dna2-K1080E and pRS316-DNA2 plasmids was trans-
formed with each of the three plasmids indicated at the right of the
ﬁgure. Transformants were grown in liquid media and cells were
spotted in 10-fold serial dilutions (10
5,1 0
4,1 0
3 and 10
2 cells) onto
plates without ( FOA) or with (+FOA) 5-FOA, followed by incuba-
tion for 3 days at 30 C, as shown. (B) Overexpression of Vts1 does not
suppress the dna2 endonuclease-deﬁcient mutant. The same plasmids
used in panel A were transformed into dna2D strain YJA1B harboring
pRS314-dna2-E680A and pRS316-DNA2 plasmids. Cells were grown as
shown in panel A.( C) Overexpression of Vts1 does not suppress
dna2D405N that lacks the N-terminal 405-amino-acid domain. The
same plasmids used in panel A were transformed into YJA2
(dna2D405N). Transformants were grown in liquid media and the
cells were spotted in 10-fold serial dilutions (10
5,1 0
4,1 0
3 and 10
2
cells) onto SD-Leu plates. The plates were incubated for 3 days at
25 Co r3 7  C as indicated.
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they doubled in cell numbers with a doubling time of
 3h (Figure 2A, open square) similar to wild type
(closed square) at the later stage (9h after incubation).
In contrast, dna2D405N grew more slowly (doubling
time,  6h) (Figure 2A, closed circle) than either
wild-type or vts1D mutant cells. The vts1D dna2D405N
double mutant cells, however, grew signiﬁcantly slower
with a doubling time of  9h (Figure 2A, open circle)
than cells harboring vts1D or dna2D405N alone.
We also tested dna2-7 alone and dna2-7 vts1D. The
vts1D dna2-7 double mutant cells displayed synergistic
growth defects at 30 C, a semipermissive temperature
for dna2-7 (Figure 2B). The vts1D dna2-7 double mutant
cells grew more poorly ( 10 fold) than cells with vts1D or
dna2-7 alone. These results, together with genetic suppres-
sion data shown above, suggest that VTS1 plays a role in a
process that requires the function of DNA2.
Vts1 stimulates endonuclease activity of Dna2 in vitro
The SAM domain of Vts1 is critical for the in vivo
posttranscriptional regulation of target mRNAs. The
vts1-A498Q mutation, containing the single substitution
(Ala into Gln) at position 498 amino acid in the SAM
domain, abolished the binding of Vts1 to SRE-RNA con-
taining a speciﬁc stem-loop structure, resulting in defects
in the posttranscriptional regulation of the target mRNAs
(22). In order to examine whether this structure-speciﬁc
RNA-binding activity of Vts1 is required for the suppres-
sion of dna2-K1080E, we prepared the vts1-A498Q mutant
allele by site-directed mutagenesis and cloned into
pRS325. The resulting plasmid, pRS325-vts1-A498Q,
was introduced into dna2D strain YJA1B harboring both
pRS314-dna2-K1080E and pRS316-DNA2. Multi-copy
expression of this mutant protein failed to restore the
growth of dna2-K1080E mutation unlike wild-type VTS1
(data not shown). This eﬀect was probably due to the poor
expression of the Vts1-A498Q mutant protein, because the
Vts1-A498Q protein was hardly detected (data not
shown). For this reason, the native promoter of
Vts1 was replaced with a GAL1 promoter to generate
pRS325-GAL(p)-VTS1 and pRS325-GAL(p)-vts1-
A498Q. When expression of Vts1-A498Q was induced by
galactose, both Vts1 and Vts1-A498Q suppressed
dna2-K1080E to similar extents (Figure 3A), indicating
that the SAM domain of Vts1 is not critical for its func-
tional interaction with Dna2.
In order to conﬁrm our in vivo observations in vitro,
both wild-type Vts1 and mutant Vts1-A498Q proteins
were puriﬁed from E. coli to near homogeneity
(Figure 3B), as described in ‘Materials and Methods’
section. Both proteins contained a hexahistidine epitope
tag in their N-terminal region. We conﬁrmed that the
epitope-tagged proteins retained the ability to suppress
dna2-K1080E (data not shown). Our preparations of
Vts1 and Vts1-A498Q were devoid of any detectable
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-
Figure 3. Puriﬁcation of Vts1 and Vts1-A498Q. (A) The
structure-speciﬁc RNA-binding activity of Vts1 is dispensable for sup-
pression of the dna2-K1080E mutant. Plasmids containing genes
indicated at the right of ﬁgure were introduced into dna2D strain
YJA1B harboring pRS314-dna2-K1080E and pRS316-DNA2 plasmids.
Cells were grown in SG-His-Trp-Leu (2% galactose without glucose)
and 10-fold serial dilutions (10
5,1 0
4,1 0
3 and 10
2 cells) were spotted
onto SG-His-Trp-Leu plates without ( FOA) or with (+FOA) 5-FOA.
The plates were incubated for 5 days at 30 C as shown. (B) An SDS–
PAGE analysis of wild-type Vts1 and mutant Vts1-A498Q (Vts1-AQ)
proteins. Both proteins were puriﬁed as described in ‘Material and
Methods’ section. Of each protein, 1mg was subjected to electrophoresis
in a 10% SDS–PAGE gel, which was then stained with Coomassie Blue
G-250. (C) Vts1 binds to the SRE-RNA substrate, while Vts1-A498Q
does not. Electrophoretic mobility shift assays were performed as
described in ‘Materials and Methods’ section. The SRE-RNA substrate
(5fmol) was incubated in the presence of increasing amounts
(0.5–20pmol) of Vts1 or Vts1-A498Q at 4 C for 10min, followed by
additional 5-min incubation at 37 C. After incubation, reaction
mixtures were subjected to electrophoresis in a 6% native
polyacrylamide gel.
wt
vts1D
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1
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Figure 2. Synergistic growth defects associated with dna2 mutations
and vts1D.( A) Cells were incubated in 32 C and the cell numbers
were measured at the time point indicated using a hematocytometer.
(B) Cells were spotted in serial 10-fold dilutions on YPD media and
plates were incubated for 3 days at the temperatures indicated.
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(Figure 4A, lanes 3 and 4). Using puriﬁed proteins, we
ﬁrst carried out electrophoretic mobility shift assays to
conﬁrm that puriﬁed Vts1 possesses SRE-RNA-binding
activity and Vts1-A498Q does not. For this purpose, the
labeled SRE-RNA substrate was prepared (see Table 1 for
their nucleotide sequence) and incubated with increasing
levels (0.05–20pmol) of either Vts1 or Vts1-A498Q
(Figure 3C). Consistent with the previous report (22),
Vts1, but not Vts1-A498Q, bound to the SRE-RNA
substrate in electrophoretic mobility shift assays
(Figure 3C).
Next, we examined the inﬂuence of Vts1 and
Vts1-A498Q on the Dna2 endonuclease activity. For this
purpose, time-course experiments were carried out with a
low level (0.25fmol) of Dna2 in the presence or absence of
Vts1 or Vts1-A498Q (each at 25fmol). As shown in
Figure 4A (lanes 5–9), Dna2-catalyzed cleavage products
slowly increased with time (up to 100min), indicating that
Dna2 was stable over this incubation time (Figure 4A,
lanes 5–9; Figure 4B, diamond). However, the rate of
cleavage by Dna2 was markedly ( 8- to 10-fold)
stimulated by the presence of either Vts1 (Figure 4A,
lanes 10–14; Figure 4B, square) or Vts1-A498Q
(Figure 4A, lanes 15–19; Figure 4B, triangle) and
plateaued after 60min of incubation. These ﬁndings
indicate that both Vts1 and Vts1-A498Q stimulate the
endonuclease activity of Dna2 with almost identical
eﬃciency, conﬁrming that the structure-speciﬁc
RNA-binding activity of Vts1 was not required for the
stimulation of the Dna2 endonuclease activity.
Increased levels of Dna2 endonuclease activity are
suﬃcient to suppress the dna2-K1080E mutation in vivo
Since both Vts1 and Vts1-A498Q stimulated the Dna2
endonuclease activity and suppressed the dna2-K1080E
mutation, we determined whether increased Dna2
endonuclease activity could rescue the growth defects of
dna2-K1080E. This question can be addressed directly by
increasing the copy number of the dna2-K1080E mutant
allele. We constructed two pRS325 plasmids in which the
dna2-K1080E mutant allele was diﬀerentially expressed,
one plasmid in which expression of dna2-K1080E was
driven by its native promoter and the other by the consti-
tutive strong ADH1 promoter. The two plasmids were
introduced into the dna2D strain YJA1B harboring both
pRS314-dna2-K1080E and pRS316-DNA2, and the extent
of suppression was examined. Expression of dna2-K1080E
in both plasmids resulted in suppression of dna2-K1080E
mutation (Figure 4C). In fact, the expression of
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Figure 4. Vts1 stimulates the endonuclease activity of Dna2 in vitro.( A) Both Vts1 and Vts1-A498Q stimulate Dna2 endonuclease activity in vitro.
Three sets of reaction mixtures were assembled on ice; one with Dna2 (0.25fmol) only (lanes 5–9), the second with Dna2 (0.25fmol) and Vts1
(25fmol) and the third with Dna2 (0.25fmol) and Vts1-A498Q (25fmol). The reaction mixtures were then incubated at 37 C for varying periods of
time (0, 2, 10, 30, 60 and 100min). Cleavage products were analyzed on a 10% denaturing polyacrylamide gel as described in ‘Materials and
Methods’ section. ‘B’ in lane 1 represents boiled. (B) The amount of product formed from reactions in panel A was plotted against the time of
incubation. (C) Overexpression of Dna2-K1080E (Dna2-KE) suppresses its own growth defects. The experimental procedures are as described in
Fig. 1A. Note that the expression of Dna2-K1080E was driven either by the ADH1 promoter or by its own promoter.
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the growth defects of dna2-K1080E more eﬃciently than
its native promoter, indicating that the increased
endonuclease activity of Dna2 could be the cause of sup-
pression. Based on this result, we concluded that elevated
levels of the Vts1 protein increase the endonuclease
activity of Dna2 and suppress the lethal phenotype of
dna2-K1080E.
Stimulation of Dna2 endonuclease by Vts1 requires
a direct protein–protein interaction
As shown in Figure 1C, overexpression of VTS1 failed to
suppress the temperature-sensitive growth defects of
dna2D405N. This mutant enzyme, lacking the N-terminal
405-amino-acid domain, possesses the same endonuclease
activity as the wild-type enzyme (13). In order to further
substantiate our notion that the stimulation of Dna2
endonuclease activity by Vts1 is responsible for the suppres-
sion observed in vivo, we examined whether increasing
amount of Vts1 or Vts1-A498Q aﬀected the endonuclease
activities of wild-type Dna2 (Figure 5A) and Dna2405N
(Figure 5B). The endonuclease activity of wild-type Dna2
was markedly stimulated ( 8-fold) in response to increasing
levels of both Vts1 and Vts1-A498Q (Figure 5A and C),
while the stimulation of Dna2405N was marginal
(<2-fold) (Figure 5B and C). This is in keeping with the
results obtained from the time-course experiments described
above (Figure 4A). In conclusion, our ﬁndings demonstrate
that the stimulation of the Dna2 endonuclease activity
by Vts1 requires the N-terminal domain of Dna2 and that
suppression of dna2-K1080E involves the stimulation of
Dna2 endonuclease activity.
Experiments using ELISA assays revealed that highly
puriﬁed Dna2 and Vts1 proteins directly interacted with
each other. Vts1 was ﬁrst adsorbed to a microtiter plate
that was incubated in the presence of increasing levels
(2–10 nM) of puriﬁed wild-type Dna2, Dna2405N and
Dna2
(1–405) (the N-terminal 405-amino-acid fragment).
After washing, the amount of Dna2 and its derivatives
adsorbed to the wells was detected with polyclonal
antibodies speciﬁc to Dna2. The polyclonal antibodies
were appropriately diluted in order to detect each Dna2
derivative to the same extent (data not shown). As shown
in Figure 5D, a speciﬁc interaction between puriﬁed Vts1
and Dna2 was observed, which increased as the level of
wild-type Dna2 was increased (Figure 5D, circle).
However, Dna2405 and Dna2
(1–405) failed to interact
with Vts1 (Figure 5D, square and triangle, respectively).
We also carried out the reciprocal experiment; Dna2 was
ﬁrst adsorbed to the wells of the microtiter plate, and Vts1
protein was then added. Detection was done with
polyclonal antibodies speciﬁc for Vts1. Consistent with
the result described above (Figure 5D), Vts1 bound to
the wells coated with wild-type Dna2, neither Dna2405
nor Dna2
(1–405) (data not shown). These ﬁndings suggest
that the interaction of Vts1 with Dna2 requires both the
N-terminal domain and some other region of Dna2.
Taken together, our in vitro results are in keeping with
in vivo observations that VTS1 fails to suppress the
temperature-sensitive growth defects of dna2D405N,
further supporting the notion that the stimulation of
the Dna2 endonuclease activity by Vts1 is the direct
cause of the suppression of dna2-K1080E and that this
eﬀect is dependent on a speciﬁc protein–protein
interaction.
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Figure 5. Vts1 stimulates Dna2 endonuclease via interaction with the DNA-binding domain of Dna2. (A) Vts1 stimulates Dna2 endonuclease
in vitro. Reaction mixtures containing indicated amounts of Dna2 and either Vts1 wild-type or Vts1-A498Q (Vts1-AQ) were incubated for 15min
in 37 C. Products were analyzed on 10% denaturing polyacrylamide gel. (B) Vts1 does not stimulate Dna2405N endonuclease in vitro. Experiments
with Dna2405N were done same as described in panel A. (C) The stimulation folds of Dna2 endonuclease activity by Vts1 (or Vts1-AQ) in
reactions described in A and B were plotted. (D) Vts1-coated wells were incubated with increasing concentrations (2, 5 and 10nM) of Dna2
derivatives indicated at the top of the ﬁgure. Wells were aspirated, washed three times and bound Dna2, Dna2405N and Dna2
(1–405) were
detected by ELISA using rabbit polyclonal antibodies against Dna2. Absorbance readings at each point were corrected for background absorbance
generated with BSA-coated wells.
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Vts1 could stimulate Dna2 endonuclease activity by
recruiting Dna2 more eﬃciently to a DNA substrate.
Since this mechanism would likely require the binding of
Vts1 to DNA, we examined this possibility with diﬀerent
structures using electrophoretic mobility shift assays. The
substrates tested included single-stranded (ssDNA, 50-nt),
double-stranded (dsDNA, 50-bp), 1-nt 50-ﬂap, 27-nt
50-ﬂap (50FL), 50-overhang, 30-overhang, nicked duplex
and 1-nt gapped duplex DNAs. All substrates were con-
structed with a common 50-nt oligonucleotide (Table 1,
oligonucleotide 1). The interaction of Vts1 with ssDNA
yielded a smeared electrophoretic mobility shift
(Figure 6A, lanes 1–4) at relatively high protein levels
(>2pmol), suggesting that binding, if it occurred, was
not stable. In contrast, all other substrates containing a
duplex DNA region were more eﬃciently complexed than
the ssDNA substrate. Among them, Vts1 bound the 27-nt
50-ﬂap DNA with the greatest aﬃnity and stability, since it
formed the highest level of a discrete nucleoprotein
complex (Figure 6A, lanes 13–16). The binding of Vts1
to the 1-nt 50-ﬂap DNA (Figure 6A, lanes 9–12) was
similar to that observed with the other partial duplex
DNA substrates. Thus, Vts1 appears to bind preferentially
to a duplex containing a long 50-ssDNA ﬂap region.
In order to conﬁrm that Vts1 binds more stably to the
50-ﬂap structure than duplex DNAs, substrate-challenge
experiments were carried out. We ﬁrst incubated 5fmol
of labeled 27-nt 50-ﬂap (50FL) or simple duplex DNA
(dsDNA) with a ﬁxed amount (4pmol) of Vts1 to allow
formation of the nucleoprotein complex. As shown in
Figure 6A, the level of Vts1 (4pmol) used shifted nearly
all of the 27-nt 50FL or dsDNA substrate added. The
complexes formed were then challenged with increasing
amounts of unlabeled competitor DNAs. The addition
of increasing levels (up to 500fmol,  100-fold molar
excess) of unlabeled dsDNA as competitor had no eﬀect
on the Vts1-50FL complex (Figure 6B, closed circle), while
the Vts1-dsDNA complex was linearly reduced (up to
 60%) by the addition of unlabeled dsDNA (Figure 6B,
open circle). In contrast, the Vts1–dsDNA complex (open
circle) was aﬀected to a greater extent than the Vts1–50FL
complex (closed circle) by increasing concentrations of
unlabeled competitor 50FL DNA (Figure 6C). These
data conﬁrm that Vts1 is more stably bound to 50-ﬂap
DNA than dsDNA without a ﬂap.
Since the eﬃcient binding of Vts1 to DNA appeared to
require the presence of a ﬂap structure, DNA footprinting
analyses were carried out with the Vts1/35-nt 50FL DNA
complex. We ﬁrst determined the optimal concentration of
DNase I that partially cleaved the 35-nt 50FL DNA
labeled at the 30-end of the ﬂap strand. The amount of
DNase I required for optimal partial cleavage was 0.1U
per reaction (data not shown). The 35-nt 50FL DNA was
ﬁrst complexed with increasing levels (0.5–16pmol) of
Vts1 and then treated with DNase I (0.1U) to cleave
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Figure 6. Vts1 is a ﬂap DNA-speciﬁc-binding protein. (A) Electrophoretic mobility shift assays were performed as described in ‘Materials and
Methods’ section. Each substrate (15fmol), shown at the top of the gel, was preincubated with increasing amounts (1, 2 and 4pmol) of Vts1 at 4 C
for 10min, followed by an additional 5min of incubation at 37 C. After incubation, samples were loaded on a 6% native polyacrylamide gel and the
Vts1–DNA complexes formed were analyzed by autoradiography as described in ‘Materials and Methods’ section. The amount of substrate left was
measured and the values are presented at the bottom of the gel. (B and C) Substrate challenge assays. The Vts1–DNA complex was ﬁrst formed by
incubating 5fmol of labeled substrate (indicated at the top of the gel) with excess Vts1 (4pmol) as described in panel A. Increasing amounts (5, 20,
100 and 500fmol) of unlabeled competitor DNA were added to reactions containing the Vts1/labeled substrate complex. The amount of labeled
substrate left was plotted against the amount of unlableled competitor DNA used.
Nucleic Acids Research,2010, Vol.38, No. 5 1591unprotected regions in the DNA. Two changes in the
protection pattern were detected. At high Vts1 concentra-
tions (4–16pmol), the double-stranded region of the
ﬂap-containing strand (Figure 7, lanes 5–7) was eﬀectively
protected from DNase I digestion. This protection was
more pronounced near the duplex end and progressed
toward the ssDNA–dsDNA junction with increasing con-
centrations of Vts1 (Figure 7, compare lanes 5–7). We
noted that Vts1 had an intrinsic property to bind to
duplex DNA ends. These results as well as those described
above suggest that Vts1 binds to the single-strand ﬂap
ﬁrst, and then subsequently binds to the duplex region.
Stimulation of Dna2 endonuclease by Vts1 requires its
DNA-binding activity
To investigate whether the DNA-binding activity of Vts1
is critical for its stimulation of Dna2 endonuclease
activity, we puriﬁed two truncated fragments of Vts1,
Vts1
(1–406) (a 44-kDa N-terminal fragment, amino acid
1-406), and Vts1
SAM (a 13-kDa protein containing the
SAM domain, amino acid 407–523) (Figure 8A and B).
Vts1
(1–406) stimulated Dna2, but less eﬃciently than
wild-type Vts1 (Figure 8C, compare lanes 5–9 and
10–13), while Vts1
SAM failed to stimulate Dna2
endonuclease (Figure 8C, lanes 14–17). DNA-binding
experiments revealed that Vts1
(1–406) was capable of
binding to the 50-ﬂap DNA, while Vts1
SAM was not
(Figure 8D). The DNA-binding activity of Vts1
(1–406)
was much weaker than wild-type Vts1 (Figure 8D,
compare lanes 2–5 and 6–9). These results suggest that
the stimulation of Dna2 endonuclease activity by Vts1
depends on its ability to bind DNA. It is worthwhile to
note that Vts1
(1–406) formed a unique and distinct DNA
complex diﬀerent from the smeared high-molecular weight
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polyacrylamide gel. (D) The N-terminal fragment of Vts1 and Vts1 are able to bind 50-ﬂap DNA. Electrophoretic mobility shift assays were carried
out as described in ‘Materials and Methods’ section. The 27-nt 50-ﬂap substrate (5fmol) was incubated at 4 C for 10min in the presence of increasing
amounts (0.5, 1, 2 and 4fmol) of Vts1, followed by additional 5min of incubation at 37 C.
Vts1 -
32
30
28
26
24
22
20
18
14
12
10
8
16
1234567 1234567 Lane
6
4
3
2
5’
25nt 
5’
26nt 
35-nt 
flap 
Figure 7. DNase I protection analysis of Vts1 bound to 50-ﬂap DNA.
DNase I protection assays were carried out with the DNA substrate
indicated above the gel. The 30-end of the strand indicated above the
gel was
32P-labeled. Increasing amounts of Vts1 (0.5, 1, 2, 4, 8 and
16pmol) were preincubated at 4 C for 10min, followed by additional
5-min incubation at 37 C. DNase I (0.1U/reaction) was then added to
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reaction products were analyzed in a 15% high-resolution sequencing
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1592 Nucleic Acids Research, 2010,Vol.38, No. 5complex formed by wild-type Vts1. Thus, we conclude
that Vts1
(1–406) contains DNA-binding activity and the
SAM domain is required for the formation of higher
order complexes with DNA substrates.
Vts1 stimulates yeast Fen1 endonuclease
Yeast Fen1, Rad27, is a critical enzyme that cleaves ﬂap
structures to generate ligatable nicks. Since Vts1 is a
ﬂap-speciﬁc binding protein, we tested whether it also
stimulates the nuclease activity of Fen1. As shown in
Figure 9A, Vts1 increased ( 10fold) the Fen1
endonuclease activity. Unlike Dna2, both Vts1
(1–406) and
Vts1
SAM failed to signiﬁcantly stimulate Fen1 (Figure 9B).
Thus, full-length Vts1 is required to stimulate Fen1. As
discussed above, RPA is a potent inhibitor of Fen1, and
this inhibition was unaﬀected by the addition of Vts1
(data not shown).
Vts1 is present in nuclei
Our in vivo and in vitro ﬁndings support that Vts1 is
involved in the processing of Okazaki fragments in
yeast. If Vts1 were to play this role in vivo, we would
expect it to be present in nuclei. Based on cell images
available from the Organelle DB of S. cerevisiae
Genome Database (http://organelledb.lsi.umich.edu/
gene.php?sys_name=YOR359W), Vts1 appears to be
distributed throughout the whole cell, obscuring its detec-
tion in nuclei. In order to address this issue, we determined
whether Vts1 is also present in the nucleus. For this
purpose, yeast nuclei were isolated from spheroplasts
and three diﬀerent cellular fractions were isolated that
included cell debris (CD), nuclear fraction (NF) and
cytoplasmic fraction (CF). Each fraction was subjected
to western blotting with speciﬁc monoclonal antibodies
to detect the presence of FLAG-epitope tagged Vts1
(Vts1-FLAG) and two marker proteins, a tubulin
(cytoplasmic) and histone 3 (nuclear), were used as
controls. As expected, cell debris derived from sphero-
plasts contained both cytoplasmic and nuclear proteins,
because both a-tubulin and histone 3 were present
(Figure 9C, lane 1). In contrast, histone 3 and a-tubulin
were detected only in nuclear (Figure 9C, lane 2) and
cytoplasmic (Figure 9C, lane 3) fractions, respectively,
demonstrating that our nuclear and cytoplasmic protein
preparations were not cross-contaminated. Vts1 was
detected in both cytoplasmic and nuclear fractions
(Figure 9C, lanes 2 and 3), demonstrating that Vts1 is
also present in nuclei. This ﬁnding is in keeping with our
notion that Vts1 can function with Dna2 in nuclei.
DISCUSSION
Though dna2 helicase-deﬁcient mutant yeast cells fail to
grow in media containing glucose, they grow slowly in the
presence of poor carbon sources such as lactate and
glycerol (32). These cells are viable in the presence of
low levels of hydroxyurea that do not aﬀect the growth
of wild-type cells (data not shown). These ﬁndings suggest
that the helicase activity of Dna2 is not essential and is
dispensable under certain growth conditions unlike its
endonuclease activity. Thus, it is likely that the in vivo
function of the Dna2 helicase activity can be replaced
by other helicases or enzymes. These considerations
prompted us to screen for the genes that suppress the
growth defects of the dna2-K1080E helicase-deﬁcient
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Figure 9. Vts1 stimulates yeast Fen1 endonuclease activity. (A) The
reaction mixtures containing indicated amounts of Fen1 and
wild-type Vts1 were incubated with 50-ﬂap substrate (15fmol) for
15min in 37 C. Cleavage products were analyzed in a 10% denaturing
polyacrylamide gel. (B) The same reactions as panel A were repeated
with Vts1 and its derivatives as indicated. The amount of product
formed was plotted against the amount of Vts1 or its derivates
added. (C) Cellular localization of Vts1 in S. cerevisiae. As described
in ‘Materials and Methods’ section, nuclear and cytoplasmic fractions
were prepared from spheroplasts of two strains, YPH499 (negative
control) and YPH499 (Vts1-FLAG), that expresses endogenous
FLAG-tagged Vts1. CD, cell debris fraction; NF, nuclear fraction;
CF, cytoplasmic fraction. The fractions were subjected to western-blot
analyses in a 10% SDS–PAGE with speciﬁc monoclonal antibodies
against a-tubulin, histone 3 and the FLAG epitope. Proteins detected
were as indicated at the right of each blot.
Nucleic Acids Research,2010, Vol.38, No. 5 1593mutant to ﬁnd a new helicase involved in Okazaki
fragment processing in eukaryotes. During the course of
this work, we identiﬁed Vts1 as a genetic suppressor of
helicase-negative dna2-K1080E. Contrary to our expecta-
tion, we found that Vts1 is devoid of helicase activity and
has no eﬀect on the Dna2 helicase activity (data not
shown). Although Vts1 was originally reported to play a
role in cytoplasmic events such as posttranscriptional reg-
ulation, our ﬁndings suggested that Vts1 aﬀects nuclear
events as well, particularly in Okazaki fragment process-
ing in yeast. This conclusion is supported by a substantial
number of results presented here. These include the fol-
lowing: (i) The double mutants such as vts1D dna2D405N
and vts1D dna2-7 grew more slowly than single mutants
alone. (ii) The stimulation of Dna2 endonuclease activity
by Vts1 required speciﬁc protein–protein interactions
between the two proteins. Not only the physical interac-
tion between Vts1 and Dna2 but also the stimulation of
the Dna2 endonuclease activity by Vts1 required the
N-terminal 405-amino-acid domain of Dna2. (iii) Vts1
was shown to be a ﬂap-structure-speciﬁc DNA-binding
protein. (iv) Vts1 stimulated yeast Fen1, another
endonuclease essential for processing of Okazaki frag-
ments in eukaryotes. (v) Finally, we showed that Vts1
was present in yeast nuclei, consistent with its function
in Okazaki fragment processing.
Our biochemical and genetic data indicate that the stim-
ulation of Dna2 endonuclease activity by Vts1 is a major
factor contributing to its suppression of the dna2-K1080E
mutation. This is supported by our ﬁndings that the sup-
pression of dna2-K1080E was observed when the mutant
dna2-K1080E allele was provided in a multi-copy plasmid.
In addition, the extent of suppression depended on the
levels of Dna2-K1080E expression; suppression was
more pronounced when Dna2-K1080E expression was
driven by the strong ADH1 promoter (Figure 4C). Thus,
elevated levels of Dna2 endonuclease activity are required
to overcome the helicase deﬁciency caused by this
mutation. Since the stimulation of Dna2 endonuclease
activity by Vts1 requires its DNA-binding activity, it is
possible that the binding of Vts1 to DNA substrates
could alter the DNA structure and render it more suscep-
tible to Dna2 cleavage. However, this notion is unlikely
because the stimulation was allele-speciﬁc. Vts1 stimulated
wild-type Dna2, but not Dna2405N. In addition, Vts1
interacted with wild-type Dna2, but not Dna2405N in
ELISA assays. These results indicate that the stimulation
of Dna2 endonuclease by Vts1 requires its DNA-binding
activity and its ability to interact with Dna2. For these
reasons, we conclude that the speciﬁc and stable binding
of Vts1 to ﬂap DNA substrates contributes to eﬃcient
Okazaki fragment processing by targeting Dna2 eﬃciently
to ﬂap DNA.
Although Vts1 signiﬁcantly stimulated yeast Fen1, it
was unable to reverse the RPA inhibition of the
endonuclease activity of Fen1 (data not shown). This
ﬁnding suggests that Vts1 cannot displace RPA from
RPA-coated ﬂaps. Thus, it is possible that Vts1 binds to
the ﬂap structure less strongly, individually or
cooperatively, than RPA. In the presence of both RPA
and Vts1, Vts1 stimulated the degradation of ﬂaps
shorter than 20nt, at which RPA binds poorly (data not
shown). Though Vts1 robustly stimulated Fen1 activity in
vitro, it is unlikely that this eﬀect contributes to the sup-
pression of the dna2-K1080E mutation since Vts1 in
a multi-copy plasmid failed to suppress dna2D405N. If
suppression of the dna2-K1080E mutation occurred
solely by the stimulation of Fen1, we would expect that
overexpression of Vts1 could suppress both dna2-K1080E
and dna2D405N because overexpression of Fen1 sup-
pressed both dna2-K1080E (data not shown) and
dna2D405N (33). Therefore, it appears that the stimulation
of Fen1 by Vts1 in vivo may not be suﬃcient to suppress
dna2D405N. However, it is possible that the stimulation of
Fen1 by Vts1 could provide an explanation for more
severe growth defects observed with the double mutants,
vts1D dna2D405N and vts1D dna2-7. The following
scenario would be possible; in vts1D cells, the deletion of
VTS1 may reduce the function of Fen1 compared to that
found in wild-type cells. Despite the normal protein levels
of Fen1, the absence of Vts1 (and lack of Fen1 stimula-
tion) could lead to a decrease of Fen1 activity in vivo. This
scenario could account for the more severe growth defects
observed with vts1D dna2D405N or vts1D dna2-7
compared to the single mutation.
It is noteworthy that Vts1 can bind to duplex ends eﬃ-
ciently. This property was especially evident in the
presence of high levels of Vts1 and with substrates con-
taining a 1-nt overhang at its 30-end (data not shown).
If this were the case, the DNase I protection observed
near the duplex ends would not be physiologically
relevant during Okazaki fragment processing since
duplex ends are not available for the binding. However,
it is possible that the duplex end binding activity of Vts1
could function in other DNA transactions.
In summary, we suggest that Vts1 is involved in the
processing of Okazaki fragments, and possibly other
DNA events such as repair and recombination. During
repair and recombination, ﬂap-like structures can be
formed and they can be eﬃciently removed by Fen1 and
Dna2 in the presence of Vts1.
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